280 related articles for article (PubMed ID: 25300810)
1. A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand Syndrome.
Franchi F; Biguzzi E; Stufano F; Siboni SM; Baronciani L; Peyvandi F
Thromb Res; 2014 Dec; 134(6):1316-22. PubMed ID: 25300810
[TBL] [Abstract][Full Text] [Related]
2. A new ELISA assay for diagnosis of acquired von Willebrand syndrome.
Siaka C; Rugeri L; Caron C; Goudemand J
Haemophilia; 2003 May; 9(3):303-8. PubMed ID: 12694522
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study.
Tiede A; Priesack J; Werwitzke S; Bohlmann K; Oortwijn B; Lenting P; Eisert R; Ganser A; Budde U
J Thromb Haemost; 2008 Apr; 6(4):569-76. PubMed ID: 18208537
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome.
Hong S; Lee J; Chi H; Lee C; Nah S; Kim Y; Oh J; Moon H; Yoo B
Lupus; 2008 Sep; 17(9):846-8. PubMed ID: 18755868
[TBL] [Abstract][Full Text] [Related]
5. [Acquired von Willebrand syndrome in a patient with immune thrombocytopenic purpura].
Ihara A; Suzuki N; Matsushita T; Ichinose A
Rinsho Ketsueki; 2015 Jul; 56(7):901-4. PubMed ID: 26256928
[TBL] [Abstract][Full Text] [Related]
6. Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study.
Stuijver DJ; Piantanida E; van Zaane B; Galli L; Romualdi E; Tanda ML; Meijers JC; Büller HR; Gerdes VE; Squizzato A
Haemophilia; 2014 May; 20(3):326-32. PubMed ID: 24118466
[TBL] [Abstract][Full Text] [Related]
7. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome.
Federici AB
Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707
[TBL] [Abstract][Full Text] [Related]
8. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of inhibitors in acquired von Willebrand syndrome.
Mohri H; Motomura S; Kanamori H; Matsuzaki M; Watanabe S; Maruta A; Kodama F; Okubo T
Blood; 1998 May; 91(10):3623-9. PubMed ID: 9572997
[TBL] [Abstract][Full Text] [Related]
10. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568
[TBL] [Abstract][Full Text] [Related]
11. Association of acquired von Willebrand syndrome with AL amyloidosis.
Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC
Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535
[TBL] [Abstract][Full Text] [Related]
12. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
[TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand's syndrome: a single institution experience.
Kumar S; Pruthi RK; Nichols WL
Am J Hematol; 2003 Apr; 72(4):243-7. PubMed ID: 12666134
[TBL] [Abstract][Full Text] [Related]
14. A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis.
Rauch A; Caron C; Vincent F; Jeanpierre E; Ternisien C; Boisseau P; Zawadzki C; Fressinaud E; Borel-Derlon A; Hermoire S; Paris C; Lavenu-Bombled C; Veyradier A; Ung A; Vincentelli A; van Belle E; Lenting PJ; Goudemand J; Susen S
Thromb Haemost; 2016 May; 115(5):950-9. PubMed ID: 26791163
[TBL] [Abstract][Full Text] [Related]
15. Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias.
Dicke C; Schneppenheim S; Holstein K; Spath B; Bokemeyer C; Dittmer R; Budde U; Langer F
Ann Hematol; 2016 May; 95(6):945-57. PubMed ID: 27040683
[TBL] [Abstract][Full Text] [Related]
16. Establishing a method for in vitro investigation of mechanical parameters causing acquired von Willebrand syndrome in ventricular assist devices.
Egger C; Maas J; Hufen T; Schmitz-Rode T; Steinseifer U
Artif Organs; 2013 Sep; 37(9):833-9. PubMed ID: 23834027
[TBL] [Abstract][Full Text] [Related]
17. Acquired von Willebrand syndrome associated with Hashimoto's thyroiditis and subcutaneous mucosa-associated lymphoid tissue lymphoma.
Koyama T; Fujimoto K; Shima M
Intern Med; 2013; 52(23):2661-3. PubMed ID: 24292759
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of acquired von Willebrand syndrome.
Tiede A
Thromb Res; 2012 Dec; 130 Suppl 2():S2-6. PubMed ID: 23439003
[TBL] [Abstract][Full Text] [Related]
19. Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays.
Favaloro EJ; Mohammed S
Thromb Res; 2014 Dec; 134(6):1292-300. PubMed ID: 25300811
[TBL] [Abstract][Full Text] [Related]
20. Acquired von Willebrand syndrome--report of 10 cases and review of the literature.
Nitu-Whalley IC; Lee CA
Haemophilia; 1999 Sep; 5(5):318-26. PubMed ID: 10583513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
